Pooled Efficacy and Safety of Enlicitide, an Oral PCSK9 Inhibitor, Across Two Phase 3 Trials: CORALreef Lipids and CORALreef HeFH

2026-06-10

0

PRE

AI

C

Christie Ballantyne

E

Elina Mikhailova

A

Alberico Catapano

D

Dirk Blom

E

Emil Asprusten

P

Puja Banka

A

Alberto Cadena

S

Samar Froman

L

Laura Gellis

M

Myeongjong Kang

S

Susan Kourpanidis

N

Norman Lepor

G

Geraldine Mendizabal

J

Julio Nunez

DOI：10.1016/j.jacl.2026.05.188

Original request for help

Save

Abstract

En 中文

Yes — Merck Sharp & Dohme LLC